4.5 Article

Single Center Experience With Pediatric Patients With GATA2 Deficiency

Related references

Note: Only part of the references are listed.
Article Biophysics

Hematopoietic stem cell transplantation in children and adolescents with GATA2-related myelodysplastic syndrome

Rachel Bortnick et al.

Summary: In pediatric MDS, patients with GATA2 mutations who underwent HSCT had a 5-year overall survival of 75% and disease-free survival of 70%. Non-relapse mortality and relapse were equal contributors to treatment failure. Organ toxicities and infection rates did not show significant increase, suggesting early consideration of HSCT in young individuals with GATA2 deficiency.

BONE MARROW TRANSPLANTATION (2021)

Article Dermatology

Skin manifestations among GATA2-deficient patients

A. Polat et al.

BRITISH JOURNAL OF DERMATOLOGY (2018)

Article Hematology

GATA2 deficiency and related myeloid neoplasms

Marcin W. Wlodarski et al.

SEMINARS IN HEMATOLOGY (2017)

Review Hematology

Haematopoietic and immune defects associated with GATA2 mutation

Matthew Collin et al.

BRITISH JOURNAL OF HAEMATOLOGY (2015)

Article Immunology

The human syndrome of dendritic cell, monocyte, B and NK lymphoid deficiency

Venetia Bigley et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2011)

Article Genetics & Heredity

Emberger Syndrome-Primary Lymphedema With Myelodysplasia: Report of Seven New Cases

Sahar Mansour et al.

AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2010)